Global Cord Blood (NYSE:CO) Now Covered by StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:COGet Free Report) in a research report issued to clients and investors on Thursday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

NYSE:CO opened at $1.24 on Thursday. The firm has a market capitalization of $150.72 million, a PE ratio of 1.94 and a beta of 0.16. The business’s fifty day moving average price is $1.28 and its 200 day moving average price is $1.27. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50.

Hedge Funds Weigh In On Global Cord Blood

Large investors have recently bought and sold shares of the business. Northern Trust Corp purchased a new position in shares of Global Cord Blood during the second quarter worth about $96,000. Natixis Advisors L.P. grew its holdings in shares of Global Cord Blood by 6.6% during the first quarter. Natixis Advisors L.P. now owns 189,330 shares of the medical research company’s stock worth $729,000 after buying an additional 11,709 shares during the last quarter. Finally, Moneta Group Investment Advisors LLC grew its holdings in shares of Global Cord Blood by 99,844.5% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 26,093,520 shares of the medical research company’s stock worth $77,957,000 after buying an additional 26,067,412 shares during the last quarter.

Global Cord Blood Company Profile

(Get Free Report)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

Featured Stories

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.